Fecal Calprotectin
Role of Fecal Calprotectin in Diagnosis and Follow up of Hepatic Encephalopathy
5
A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis
9
Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth
6
Diagnostic Value of Fecal Calprotectin and Serum MMP 9 in Diagnosing Disease Activity of Ulcerative Colitis
11
A New Immunofluorescence Assay for Fecal Calprotectin Distinguishes Inflammatory Bowel Disease from Functional Bowel Disease
10
Fecal Calprotectin and Transforming Growth Factor-b1 in the Evaluation of Disease Activity in Patients with Ulcerative Colitis
9
Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes
7
Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study
9
VALUE OF FECAL CALPROTECTIN AS A NON-INVASIVE MARKER DIFFERENTIATING ORGANIC FROM FUNCTIONAL BOWEL DISEASES
6
A distinct gut microbiota composition in patients with ankylosing spondylitis is associated with increased levels of fecal calprotectin
12
Fecal Calprotectin Level of Breast Milk-Formula vs Formula Feeding in Preterm and Low Birth Weight Neonates with Necrotizing Enterocolitis
6
Magnetic resonance enterography, colonoscopy, and fecal calprotectin correlate in colonic Crohn’s disease
9
Can Giardia Infection Impair the Diagnostic Level of Fecal Calprotectin in Patients with Inflammatory Bowel Disease? A Case Report
5
Fecal calprotectin in inflammatory bowel disease
9
Clinical outcomes at 12 months and risk of inflammatory bowel disease in patients with an intermediate raised fecal calprotectin : a ‘real world’ view
8
Correlation between fecal calprotectin levels, disease severity and the hypervirulent ribotype 027 strain in patients with Clostridium difficile infection
5
Fecal Occult Blood and Fecal Calprotectin as Point-of-Care Markers of Intestinal Morbidity in Ugandan Children with Schistosoma mansoni Infection
9
Fecal Calprotectin as an Activity Marker of Inflammatory Bowel Disease in Children
8
Fecal calprotectin and lactoferrin in comparison with colonoscopy in differentiating of inflammatory bowel disease from irritable bowel syndrome
6
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial
9